FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARAMACIES WITHOUT BIAS.
Data Elements
DEMOGRAPHICS
Diagnosis
Age
Gender
Race / Ethnicity
BMI
Height / Weight
PT CHARACTERISTICS
Hemophilia Severity
IV Access Method
Target Joints
Prophylaxis vs. Breakthrough Bleeding Products
Inhibitor Use
Last Bleed Date
Number of Bleeds
PRIOR HISTORY
First Diagnosis of Hemophilia Date
Prior Regimen
Prior Treatment Status (new to therapy or refill)
Duration of Therapy
Reason for Switch
PT ADHERENCE
Current Therapy
Duration
Dose
Prophylaxis Product Use
Bleeding Product Use
% Doses Taken
% Doses Missed
PROVIDERS
Type (Physician, NP, PA)
Specialty
Academic vs Community
Specialty Pharmacy vs. Hemophilia Treatment Center
PAYERS
Type (Commercial, Medicare, Medicaid, Dual Eligible)
Payer Name
Self-Pay and Patient Assistance
Eligibility
Correct PA form
Denial Reason
PA TIMELINE
Copay Amount
PA Submitted Date
Approval / Denial Date
Appeals Submitted
DISPENSING INFO
Current Treatment Regimen Rx
Intended Regimen
Actual Regimen
Duration
Dispensed Regimen
Duration / Refills
Gaps in Therapy
Publications
2018
A Retrospective, Observational Study of BAX 855 in Clinical Practice in the United States
J. Booth, M. Watt, S. Milligan, L. Aledort
Poster Presented at: Academy of Managed Care Pharmacy (AMCP)
